A5V4d
A5V4d
A5V4d
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Feverish illness in children<br />
limitation. Physical methods may also cause shivering if the cooling is too much or too quick. 213 This<br />
may cause vasoconstriction and an increase in temperature and metabolism.<br />
Because there is limited evidence regarding clothing of the feverish child, the GDG agreed by<br />
consensus that children with fever should be clothed appropriately for their surroundings, with the aim<br />
of preventing overheating or shivering. The major consideration should be the comfort of the child,<br />
and the prevention of over-rapid cooling that may cause shivering which may be distressing for child<br />
and parents. Care also needs to be taken not to overdress febrile children. It is not possible to be<br />
prescriptive about this because of varying environmental and other conditions, and the provision of<br />
information about appropriate clothing is an important role for healthcare professionals. In view of the<br />
lack of evidence from clinical studies for or against the use of physical cooling methods, the GDG<br />
concluded that research in this area may be beneficial.<br />
Recommendations<br />
Number Recommendation<br />
198<br />
Physical interventions for reducing temperature<br />
77 Tepid sponging is not recommended for the treatment of fever. [2007]<br />
78 Children with fever should not be underdressed or over-wrapped. [2007]<br />
Drug interventions<br />
The primary method of temperature control is the use of antipyretic drugs such as paracetamol and<br />
ibuprofen. Unlike the physical methods previously discussed, these do treat the proximal cause of<br />
fever, the increased hypothalamic set-point, although neither physical nor pharmacological methods<br />
treat the ultimate cause, for example an underlying infection. The GDG sought to identify the most<br />
appropriate pharmacological treatment for fever (as distinct from the cause of the fever), considering<br />
not only antipyretic efficacy but also safety and cost.<br />
Review question<br />
The clinical question outlined in the scope for the update is to establish the ’Effect on fever and<br />
associated symptoms of treatment with:<br />
paracetamol alone or non-steriodal anti-inflammatory drugs (NSAIDs) alone, compared<br />
with placebo and with one another<br />
alternating paracetamol and NSAIDs, compared with placebo, either drug alone, and<br />
taking both at the same time<br />
paracetamol and NSAIDs taken at the same time, compared with placebo, and either<br />
drug alone and either drug alone.’<br />
Although the question states that any NSAID will be included, after assessment of available evidence,<br />
and based on the experience of the GDG, it was apparent that ibuprofen is the only NSAID in<br />
common use in the UK and it is the only NSAID licenced for this indication in children.<br />
This question includes ten specific comparisons:<br />
paracetamol compared with placebo<br />
ibuprofen compared with placebo<br />
paracetamol and ibuprofen combined compared with placebo<br />
paracetamol and ibuprofen alternating compared with placebo<br />
paracetamol compared with ibuprofen<br />
paracetamol compared with paracetamol and ibuprofen combined<br />
paracetamol compared with paracetamol and ibuprofen alternating<br />
2013 Update